Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas V Faller

Showing results (31-40 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Biological Chemistry|December 15, 2006
Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesisMarc E Lenburg, Anupama Sinha, Douglas V Faller, et al.
Experimental Cell Research|April 2, 2002
Desensitization of the PDGFbeta receptor by modulation of the cytoskeleton: the role of p21(Ras) and Rho family GTPasesLigaya L Stice, Lora W Forman, Chang S Hahn, et al.
Carcinogenesis|May 20, 2008
Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genesYan Dai, Duyen Ngo, Johanna Jacob, et al.
Blood|December 14, 2011
Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agentsSajal K Ghosh, Susan P Perrine, Robert M Williams, et al.
Bioresearch Open Access|March 22, 2013
Butyrate histone deacetylase inhibitorsKosta Steliou, Michael S Boosalis, Susan P Perrine, et al.
Chemical Biology & Drug Design|June 21, 2006
Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor modelsRegine Bohacek, Michael S Boosalis, Colin McMartin, et al.
Cancer Biology & Therapy|February 5, 2008
Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progressionHongjie Pan, Fangming Gao, Panagiotis Papageorgis, et al.
Blood Cells, Molecules & Diseases|December 13, 2006
Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agentsSajal K Ghosh, Lora W Forman, Idowu Akinsheye, et al.
Drug Development Research|June 26, 2015
Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of ageKosta Steliou, Douglas V Faller, Carl A Pinkert, et al.
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson DiseasesMichael H Irwin, Walter H Moos, Douglas V Faller, et al.
Pageof 13

Showing results (31-40 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Biological Chemistry|December 15, 2006
Tumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesisMarc E Lenburg, Anupama Sinha, Douglas V Faller, et al.
Experimental Cell Research|April 2, 2002
Desensitization of the PDGFbeta receptor by modulation of the cytoskeleton: the role of p21(Ras) and Rho family GTPasesLigaya L Stice, Lora W Forman, Chang S Hahn, et al.
Carcinogenesis|May 20, 2008
Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genesYan Dai, Duyen Ngo, Johanna Jacob, et al.
Blood|December 14, 2011
Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agentsSajal K Ghosh, Susan P Perrine, Robert M Williams, et al.
Bioresearch Open Access|March 22, 2013
Butyrate histone deacetylase inhibitorsKosta Steliou, Michael S Boosalis, Susan P Perrine, et al.
Chemical Biology & Drug Design|June 21, 2006
Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor modelsRegine Bohacek, Michael S Boosalis, Colin McMartin, et al.
Cancer Biology & Therapy|February 5, 2008
Aberrant activation of gamma-catenin promotes genomic instability and oncogenic effects during tumor progressionHongjie Pan, Fangming Gao, Panagiotis Papageorgis, et al.
Blood Cells, Molecules & Diseases|December 13, 2006
Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agentsSajal K Ghosh, Lora W Forman, Idowu Akinsheye, et al.
Drug Development Research|June 26, 2015
Bioprotective carnitinoids: lipoic acid, butyrate, and mitochondria-targeting to treat radiation injury: mitochondrial drugs come of ageKosta Steliou, Douglas V Faller, Carl A Pinkert, et al.
Drug Development Research|February 23, 2016
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson DiseasesMichael H Irwin, Walter H Moos, Douglas V Faller, et al.
Pageof 13